In the subgroup analysis of specific cancer type, we found high expression of galectin-3 correlated with reduced OS in colorectal cancer, ovarian cancer and non-small cell lung cancer (pooled HR = 3.05, 95% CI 2.13–4.35, I2= 0.0%, p = 0.734; pooled HR = 2.24, 95% CI 1.38–3.64, I2= 0.0%, p = 0.910; pooled HR = 2.07, 95% CI 1.48–2.88, I2= 0.0%, p = 0.563; respectively) (Fig. 2b). Here, LGALS3 is linked to ovarian carcinoma.